tiprankstipranks
Advertisement
Advertisement

TSHA Stock Latest News

Taysha Gene Therapies falls -11.0%
The FlyTaysha Gene Therapies falls -11.0%
13h ago
TSHA
Buy Rating Reaffirmed on Taysha’s Superior Trial Rigor and Safety Profile; $12 Price Target Maintained
PremiumRatings
Buy Rating Reaffirmed on Taysha’s Superior Trial Rigor and Safety Profile; $12 Price Target Maintained
13d ago
TSHA
Taysha Gene Therapies price target raised to $15 from $12 at Baird
PremiumThe Fly
Taysha Gene Therapies price target raised to $15 from $12 at Baird
14d ago
TSHA
Taysha Gene Therapies Announces Major Equity Financing Deal
PremiumCompany Announcements
Taysha Gene Therapies Announces Major Equity Financing Deal
18d ago
8K
TSHA
Taysha Gene Therapies management to meet with Piper Sandler
PremiumThe Fly
Taysha Gene Therapies management to meet with Piper Sandler
18d ago
TSHA
Taysha Gene Therapies 32.5M share Spot Secondary priced at $6.00
PremiumThe FlyTaysha Gene Therapies 32.5M share Spot Secondary priced at $6.00
19d ago
TSHA
Closing Bell Movers: Micron soars 14% after beat and raise
Premium
The Fly
Closing Bell Movers: Micron soars 14% after beat and raise
19d ago
MU
ARM
Taysha Gene Therapies announces $200M common stock offering
Premium
The Fly
Taysha Gene Therapies announces $200M common stock offering
19d ago
TSHA
Taysha Gene Therapies price target raised to $14 from $10 at BMO Capital
PremiumThe Fly
Taysha Gene Therapies price target raised to $14 from $10 at BMO Capital
21d ago
TSHA
Taysha Gene Therapies price target raised to $14 from $10 at BMO Capital
PremiumThe Fly
Taysha Gene Therapies price target raised to $14 from $10 at BMO Capital
21d ago
TSHA
Taysha Gene Therapies price target raised to $10 from $9 at BofA
PremiumThe Fly
Taysha Gene Therapies price target raised to $10 from $9 at BofA
21d ago
TSHA
Taysha Gene Therapies price target raised to $11 from $8 at Citizens
PremiumThe Fly
Taysha Gene Therapies price target raised to $11 from $8 at Citizens
21d ago
TSHA
Taysha Completes REVEAL Dosing, Advances Rett Gene Therapy
PremiumCompany AnnouncementsTaysha Completes REVEAL Dosing, Advances Rett Gene Therapy
22d ago
8K
TSHA
Taysha Gene Therapies completes dosing in REVEAL pivotal trial
Premium
The Fly
Taysha Gene Therapies completes dosing in REVEAL pivotal trial
22d ago
TSHA
Taysha Gene Therapies Shareholders Back Governance and Leadership
Premium
Company Announcements
Taysha Gene Therapies Shareholders Back Governance and Leadership
1M ago
8K
TSHA
ASPIRE Rett Syndrome Trial Puts Taysha’s TSHA-102 Gene Therapy in Focus for Investors
PremiumCompany Announcements
ASPIRE Rett Syndrome Trial Puts Taysha’s TSHA-102 Gene Therapy in Focus for Investors
2M ago
TSHA
FDA Commissioner Marty Makary resigns
PremiumThe Fly
FDA Commissioner Marty Makary resigns
2M ago
AZN
BMY
Taysha Gene Therapies Ramps Up Ahead of TSHA-102 BLA
PremiumCompany Announcements
Taysha Gene Therapies Ramps Up Ahead of TSHA-102 BLA
2M ago
TSHA
Whitney Ijem Reiterates Buy Rating and Maintains $17 Price Target on Clinical Momentum and Strong Cash Runway
PremiumRatings
Whitney Ijem Reiterates Buy Rating and Maintains $17 Price Target on Clinical Momentum and Strong Cash Runway
2M ago
TSHA
Taysha Gene Therapies reports Q1 EPS (12c), consensus (10c)
PremiumThe FlyTaysha Gene Therapies reports Q1 EPS (12c), consensus (10c)
2M ago
TSHA
Unusually active option classes on open April 16th
Premium
The Fly
Unusually active option classes on open April 16th
3M ago
PEP
BULL
Buy Rating on Taysha Gene Therapies Driven by Strong Leadership, Strategic Positioning, and Attractive Risk‑Reward Upside
Premium
Ratings
Buy Rating on Taysha Gene Therapies Driven by Strong Leadership, Strategic Positioning, and Attractive Risk‑Reward Upside
3M ago
TSHA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >